DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 54.7. According to RSI analysis, drreddy is marginally strong. 6.0 DRREDDY RSI Chart
MACD (?) MACD: 20.7 and Signal Line: 16.0. According to MACD analysis, drreddy is technically strong. 8.0 DRREDDY MACD Chart
Simple Moving Average (?) 20-day simple moving average just got above it's 50-day simple moving average which is a positive signal. According to simple moving average analysis, drreddy is facing resistance from it's 200-day simple moving average at 2917.155 and support level is at 2.61e+03. 8.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, drreddy is facing resistance from it's 200-day exponential moving average at 2849.624 and support level is at 2.63e+03. 7.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.666. 5.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 2614.9737 and 2570.175. And resistance is at 2760.0. 2.0 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 58.7 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 19.7 which means DRREDDY is in a trading range and there is no trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
June 27, 2017
Open Price 2630.25
High Price 2670.0
Low Price 2630.25
Close Price 2653.1
Absolute Change 9.4
Percentage Change 0.356%
Weekly Change -0.164%
Monthly Change 9.37%
Yearly Change -13.2%
52-week high 3689.85
52-week low 2380.35
Corporate Actions
ExDate Purpose
July 17, 2017 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.486
Confidence in Beta1.15%
Market Capital Rs. 45256.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 33.5
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 27 June 2017: Deliverable Quantity:1.35e+05 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 27 June 2017: Daily Volatility:0.2522 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 27 June 2017: PCR_OI:0.389 PCR:0.414 NA DRREDDY PCR Chart
Premium (?) 27 June 2017 Premium: 7.9 Futures OI:1764200.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 27 June 2017: Price:2653.1 Put with maximum OI:2600.0 Call with maximum OI:2700.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
June 29, 2017 2661.0 1764200.0 3406.0 4043.0 2653.1
July 27, 2017 2653.5 834400.0 2193.0 2779.0 2653.1
August 31, 2017 2645.0 2000.0 1.0 1.0 2653.1

Announcements

June 20, 2017 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 20, 2017, titled " Dr. Reddy s Laboratories Limited announces filing of Annual Report on Form 20-F for FY2017 .".
June 20, 2017 Dr.Allotment of ESOP/ESPS. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of Equity Shares on exercise of ESOP.
See all Announcements

Board Meetings

Date Meeting Date Purpose
April 18, 2017 May 12, 2017 intResults/Dividendter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2017 and recommend dividend, if any, for the financial year 2016-17. Further, that the Company s trading window for dealing in securities by the Insiders is closed from April 26, 2017 and ending on May 14, 2017 (both days inclusive).
January 10, 2017 February 04, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 2592 Rs. 2611 Rs. 2632 Rs. 2651 Rs. 2672 Rs. 2691 Rs. 2712